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Purpose/Objective: Pre-treatment imaging based on 
ultrasound (US) images was first developed using 
transabdominal probes but several issues linked to image 
quality and probe pressure1 were reported. The aim of this 
work was to evaluate a non-invasive transperineal (TP) US 
probe comparing its registration results with cone beam CT 
(CBCT) on patients treated for a prostate cancer, with 
prostate in situ or after prostatectomy.  
Materials and Methods: 10 prostate patients (cohort A) and 
14 post-prostatectomy patients (cohort B) were imaged with 
the TP probe (Clarity, Elekta), which acquires 3D images 
using an automated motorized sweep. During the planning CT 
session, a reference US (USref) image was acquired with the 
patient in the same position as that of the CT acquisition. A 
reference positioning volume (RPV) was delineated on the 
USref image (Figure 1). For each treatment session, a daily US 
(USday) image was acquired and manually registered on the 
USref image using a RPV projection. A CBCT image was 
acquired right after and registered on the reference CT. The 
differences between CBCT and TP-US shifts were analysed on 
320 and 453 paired USday/USref and CBCT/CT images for the 
cohorts A and B, respectively. Finally, the systematic 
difference found between CBCT and US shifts was 
retrospectively calculated on the first 5 sessions and applied 




Results: The US system was well tolerated by the patients. 
All images were of good quality for the registration of the 
two cohorts. On the raw data, shifts agreements at ± 5 mm 
were above 80 %, with the best agreement obtained in the 
lateral direction for both localizations (≥ 97.6 %). Average 
differences between the 2 modalities were 2.2 ± 3.2 mm, -
0.2 ± 2.5 mm and -0.3 ± 2.7 mm for the cohort A, and 1.5 ± 
2.6 mm, -1.6 ± 3.2 mm and -0.5 ± 2.3 mm for the cohort B, in 
the axial, longitudinal and lateral directions respectively. 
These results were comparable to other inter modalities, 
e.g., CBCT soft tissue registration versus fiducial markers 
with MV-EPI registration2. Correcting the systematic shifts 
between the 2 image modalities on the base of the first 5 
fractions enabled the percentage of agreement to be greater 
than 93 % for all directions and localizations and the average 
differences to be close to 0 mm (≤ 0.3 mm whatever the 
direction or localization). Therefore, correcting systematic 
shifts drastically improved the results. 
Conclusions: TP-US based localization of the prostate or the 
prostate bed is a feasible method to ensure accurate delivery 
of treatment plans. This device represents an attractive 
alternative to invasive and/or irradiating imaging modalities.  
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